Vivos Therapeutics, Inc. (VVOS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 0.51 |
| Open | 0.52 |
| Day High | 0.52 |
| Day Low | 0.45 |
| 52-Week High | 7.95 |
| 52-Week Low | 0.45 |
| Volume | 303,110 |
| Average Volume | 1.45M |
| Market Cap | 2.74M |
| PE | -0.22 |
| EPS | -2.14 |
| Moving Average 50 Days | 0.8 |
| Moving Average 200 Days | 1.89 |
| Change | -0.05 |
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
GlobeNewswire Inc.
Feb 05, 2026 1:45 PM GMT
Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness market LITTLETON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device an
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
GlobeNewswire Inc.
Jan 20, 2026 10:31 PM GMT
LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing disorders, including obstructive
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
GlobeNewswire Inc.
Jan 16, 2026 1:00 PM GMT
LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing disorders, including obstructive sl